SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-061680
Filing Date
2011-03-10
Accepted
2011-03-10 08:27:12
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1495172
2 LIST OF SUBSIDIARIES dex211.htm EX-21.1 859
3 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1636
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 6319
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 6319
6 CERTIFICATIONS OF CEO AND CFO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4297
7 GRAPHIC g158631g94w35.jpg GRAPHIC 52737
  Complete submission text file 0001193125-11-061680.txt   1588597
Mailing Address 245 FIRST STREET 3RD FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET 3RD FLOOR CAMBRIDGE MA 02142 617-301-7000
Zalicus Inc. (Filer) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51171 | Film No.: 11676787
SIC: 2834 Pharmaceutical Preparations